Based on PubMed | Are skin rashes an early sign of endometrial cancer, and what types of rashes should prompt medical evaluation?

Most skin rashes are not an early sign of endometrial (uterine) cancer. The most common early symptoms of endometrial cancer are gynecologic, especially abnormal vaginal bleeding or spotting after menopause, bleeding between periods, and new or unusual vaginal discharge, not skin changes. ^{[1] [2]} However, certain skin findings can occur later as treatment side effects or, rarely, as paraneoplastic (cancer‑related) skin syndromes, and these may warrant medical evaluation. ^{[3] [4]}

---

What usually signals endometrial cancer

• Abnormal uterine bleeding is the hallmark early symptom postmenopausal bleeding, bleeding between periods, or unusually heavy or frequent bleeding after age 40. ^{[1] [5]}
• Other possible signs include pelvic pain, pain with intercourse, difficulty or pain with urination, and unexplained weight loss these tend to occur in later stages. ^{[2] [6]}

If you have any abnormal vaginal bleeding, it’s important to seek prompt evaluation. Bleeding after menopause should always be checked. ^{[1] [2]}

---

When skin rashes are related

1) Treatment‑related skin reactions

Skin changes are common during therapy for endometrial cancer, particularly with chemotherapy (such as carboplatin and paclitaxel) and immunotherapy (such as durvalumab or dostarlimab). These reactions are side effects of treatment, not early signs of the cancer itself. ^{[3] [4]}

• Chemotherapy can cause rash, itching, redness, skin peeling or blisters, and infusion‑site reactions; allergic reactions can present with rash plus shortness of breath, wheeze, fever, or dizziness and need urgent care. ^[3]
• Immunotherapy can trigger immune‑related skin toxicity, ranging from itchy rashes to blistering and ulceration; “radiation recall” can cause redness, peeling, and blistering in areas that previously received radiation. ^[4]
• Supportive care often includes gentle moisturizers and avoiding irritants, but new or worsening rashes during treatment should be reported to your oncology team. ^{[7] [8]}

2) Rare paraneoplastic skin syndromes

A small number of people develop skin conditions that are indirectly caused by a cancer (paraneoplastic dermatoses). These are uncommon but can sometimes precede, coincide with, or signal recurrence of a malignancy, including endometrial cancer. ^[9]

• Reported associations with endometrial cancer include:
  • Malignant acanthosis nigricans (sudden, widespread dark, velvety skin thickening in body folds). ^[9]
  • Tripe palms (thickened, velvety, ridged palms resembling tripe). ^[9]
  • Acquired hypertrichosis lanuginosa (sudden growth of fine, soft “lanugo” hair on the face and body), which has been documented alongside endometrial adenocarcinoma and can improve after cancer treatment. ^{[10] [9]}
  • Other rare syndromes in women with gynecologic malignancies include dermatomyositis, Sweet syndrome, and erythema gyratum repens. ^[9]

Because these conditions are rare and can have other causes, they require careful dermatologic and systemic evaluation. Sudden onset of these distinctive patterns especially in older adults should prompt a medical work‑up. ^[9]

---

Rashes that should prompt medical evaluation

• Any rash with systemic allergy signs during chemotherapy or immunotherapy rash with shortness of breath, wheeze, fever, chills, dizziness, or swelling needs immediate attention due to risk of hypersensitivity. ^[3]
• Rapidly spreading, blistering, or ulcerating rash, or a rash in a previously irradiated area, especially while on immunotherapy, should be reported promptly. ^[4]
• Distinctive paraneoplastic patterns (sudden, widespread acanthosis nigricans; tripe palms; new fine lanugo‑type hair growth) deserve evaluation to rule out an internal cancer or recurrence. ^{[9] [10]}

---

What to do if you notice a rash

• If you are in treatment for endometrial cancer and develop a new or worsening rash, let your oncology team know as soon as possible; they can determine if it’s a common side effect or something more serious. ^{[7] [8]}
• For unusual, sudden, or severe rashes especially those with blisters, ulcers, or whole‑body symptoms seek urgent care. ^{[4] [3]}
• If you are not on treatment and notice unusual skin changes like sudden acanthosis nigricans, tripe palms, or lanugo‑type hair growth, consider evaluation with your clinician; while rare, these can occasionally be linked to internal cancers and merit a broader work‑up. ^{[9] [10]}

---

Key takeaways

• Skin rashes are generally not an early sign of endometrial cancer; abnormal vaginal bleeding is the most common early warning sign. ^{[1] [2]}
• Rashes are more often related to treatments (chemo or immunotherapy) or are unrelated skin conditions. ^{[3] [4]}
• Rare paraneoplastic rashes exist and, if present, should prompt medical evaluation. ^{[9] [10]}

If you’re experiencing any abnormal uterine bleeding or have a concerning rash, discussing the specifics with your clinician can help determine the right next steps tailored to your situation.